Mohamed, Ibrahim2015-03-162015-03-162005http://hdl.handle.net/123456789/7045This paper had been presented for promotion at the university of Khartoum. To get the full text please contact the other at brahimelhassan@iend.orgPost kala-azar dermal leishmaniasis (PKDL) is a common skin condition that follows successful treatment of visceral leishmaniasis (VL) in Sudanese patients. Lesions persist for years in 15% of patients and are viewed as reservoirs for the disease. Drug treatment is protracted, toxic and costly. Cure is strongly correlated with conversion in the leishmanin skin test.PKDL, Immunochemotherapy, alum/ALM+BCG candidate vaccineArticle